Annual CFF
-$125.43 M
-$151.45 M-581.89%
December 31, 2021
Summary
- As of February 12, 2025, AMYT annual cash flow from financing activities is -$125.43 million, with the most recent change of -$151.45 million (-581.89%) on December 31, 2021.
- During the last 3 years, AMYT annual CFF has fallen by -$128.69 million (-3941.53%).
Performance
AMYT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
-$5.06 M
-$1.58 M-45.32%
September 30, 2022
Summary
- As of February 12, 2025, AMYT quarterly cash flow from financing activities is -$5.06 million, with the most recent change of -$1.58 million (-45.32%) on September 30, 2022.
- Over the past year, AMYT quarterly CFF has dropped by -$3.30 million (-188.31%).
Performance
AMYT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
-$128.14 M
-$3.30 M-2.65%
September 30, 2022
Summary
- As of February 12, 2025, AMYT TTM cash flow from financing activities is -$128.14 million, with the most recent change of -$3.30 million (-2.65%) on September 30, 2022.
- Over the past year, AMYT TTM CFF has dropped by -$152.70 million (-621.68%).
Performance
AMYT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMYT Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -581.9% | -188.3% | -621.7% |
3 y3 years | -3941.5% | -111.7% | -294.3% |
5 y5 years | -529.4% | - | -294.3% |
AMYT Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | +89.0% | +2212.1% | +2.6% | at low |
5 y | 5-year | -290.2% | at low | -115.3% | +2212.1% | -294.3% | at low |
alltime | all time | -290.2% | at low | -111.7% | +2212.1% | -294.3% | at low |
Amryt Pharma Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2022 | - | -$5.06 M(+45.3%) | -$128.14 M(+2.6%) |
Jun 2022 | - | -$3.48 M(+30.1%) | -$124.83 M(-1.1%) |
Mar 2022 | - | -$2.67 M(-97.7%) | -$126.25 M(+0.7%) |
Dec 2021 | -$125.43 M(-581.9%) | -$116.92 M(+6566.1%) | -$125.43 M(-610.7%) |
Sep 2021 | - | -$1.75 M(-64.1%) | $24.56 M(-0.9%) |
Jun 2021 | - | -$4.89 M(+163.6%) | $24.80 M(-3.4%) |
Mar 2021 | - | -$1.86 M(-105.6%) | $25.68 M(-1.3%) |
Dec 2020 | $26.03 M(-60.5%) | $33.06 M(-2276.7%) | $26.03 M(+149.3%) |
Sep 2020 | - | -$1.52 M(-62.1%) | $10.44 M(-81.1%) |
Jun 2020 | - | -$4.01 M(+166.3%) | $55.26 M(-6.0%) |
Mar 2020 | - | -$1.51 M(-108.6%) | $58.76 M(-10.9%) |
Dec 2019 | $65.94 M | $17.48 M(-59.6%) | $65.94 M(+36.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2019 | - | $43.30 M(-8623.2%) | $48.47 M(+838.0%) |
Jun 2019 | - | -$508.00 K(-109.0%) | $5.17 M(-9.0%) |
Mar 2019 | - | $5.67 M | $5.67 M |
Dec 2018 | $3.27 M(-88.8%) | - | - |
Dec 2017 | $29.21 M(+136.4%) | - | - |
Dec 2016 | $12.36 M(-5865.9%) | - | - |
Dec 2015 | -$214.30 K(<-9900.0%) | - | - |
Mar 2015 | $0.00(-100.0%) | - | - |
Mar 2014 | $14.97 M(-56.8%) | - | - |
Mar 2013 | $34.69 M(>+9900.0%) | - | - |
Mar 2012 | $123.30 K(-79.7%) | - | - |
Dec 2007 | $606.80 K | - | - |
FAQ
- What is Amryt Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Amryt Pharma?
- What is Amryt Pharma annual CFF year-on-year change?
- What is Amryt Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amryt Pharma?
- What is Amryt Pharma quarterly CFF year-on-year change?
- What is Amryt Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amryt Pharma?
- What is Amryt Pharma TTM CFF year-on-year change?
What is Amryt Pharma annual cash flow from financing activities?
The current annual CFF of AMYT is -$125.43 M
What is the all time high annual CFF for Amryt Pharma?
Amryt Pharma all-time high annual cash flow from financing activities is $65.94 M
What is Amryt Pharma annual CFF year-on-year change?
Over the past year, AMYT annual cash flow from financing activities has changed by -$151.45 M (-581.89%)
What is Amryt Pharma quarterly cash flow from financing activities?
The current quarterly CFF of AMYT is -$5.06 M
What is the all time high quarterly CFF for Amryt Pharma?
Amryt Pharma all-time high quarterly cash flow from financing activities is $43.30 M
What is Amryt Pharma quarterly CFF year-on-year change?
Over the past year, AMYT quarterly cash flow from financing activities has changed by -$3.30 M (-188.31%)
What is Amryt Pharma TTM cash flow from financing activities?
The current TTM CFF of AMYT is -$128.14 M
What is the all time high TTM CFF for Amryt Pharma?
Amryt Pharma all-time high TTM cash flow from financing activities is $65.94 M
What is Amryt Pharma TTM CFF year-on-year change?
Over the past year, AMYT TTM cash flow from financing activities has changed by -$152.70 M (-621.68%)